Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2625 USD | -4.58% | -12.50% | -4.48% |
05-09 | Transcript : MariMed Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-08 | MariMed Inc. Provides Earning Guidance for the Full Year 2024 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 139 | 143.3 | 288.6 | 120.9 | 103.4 | 99.66 | - |
Enterprise Value (EV) 1 | 139 | 143.3 | 283.2 | 147 | 158.4 | 174.4 | 168.8 |
P/E ratio | -1.58 x | 47 x | 43.3 x | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.05 x | 2.81 x | 2.38 x | 0.9 x | 0.7 x | 0.62 x | 0.56 x |
EV / Revenue | 3.05 x | 2.81 x | 2.33 x | 1.1 x | 1.07 x | 1.09 x | 0.95 x |
EV / EBITDA | - | - | 6.57 x | 4.54 x | 6.42 x | 7.26 x | 4.64 x |
EV / FCF | - | - | 15.8 x | -30.4 x | -13 x | -41.5 x | 30.1 x |
FCF Yield | - | - | 6.35% | -3.28% | -7.72% | -2.41% | 3.32% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 225,065 | 304,817 | 333,653 | 339,462 | 376,126 | 379,644 | - |
Reference price 2 | 0.6178 | 0.4700 | 0.8650 | 0.3562 | 0.2748 | 0.2625 | 0.2625 |
Announcement Date | 20-04-01 | 21-03-23 | 22-03-16 | 23-03-01 | 24-03-06 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 45.6 | 50.9 | 121.5 | 134 | 148.6 | 160.5 | 178.1 |
EBITDA 1 | - | - | 43.13 | 32.38 | 24.67 | 24 | 36.4 |
EBIT | - | - | 26.86 | 20.37 | - | - | - |
Operating Margin | - | - | 22.12% | 15.2% | - | - | - |
Earnings before Tax (EBT) | - | - | 23.82 | - | - | - | - |
Net income | -81.18 | - | 7.225 | - | - | - | - |
Net margin | -178.02% | - | 5.95% | - | - | - | - |
EPS | -0.3900 | 0.0100 | 0.0200 | - | - | - | - |
Free Cash Flow 1 | - | - | 17.98 | -4.829 | -12.22 | -4.2 | 5.6 |
FCF margin | - | - | 14.8% | -3.6% | -8.22% | -2.62% | 3.14% |
FCF Conversion (EBITDA) | - | - | 41.69% | - | - | - | 15.38% |
FCF Conversion (Net income) | - | - | 248.89% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 20-04-01 | 21-03-23 | 22-03-16 | 23-03-01 | 24-03-06 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 33.21 | 31.04 | 31.28 | 32.99 | 33.91 | 35.83 | 34.38 | 36.52 | 38.8 | 38.9 | 37.93 | 38.9 | 41 | 42.6 |
EBITDA 1 | 12.92 | 8.262 | 10.36 | 8.937 | 8.597 | 4.486 | 7.076 | 6.312 | 6.055 | 5.233 | 4.661 | 5.2 | 6.5 | 7.6 |
EBIT | 6.619 | 1.204 | - | - | 5.736 | 3.089 | - | - | - | - | - | - | - | - |
Operating Margin | 19.93% | 3.88% | - | - | 16.91% | 8.62% | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | 6.132 | 0.7681 | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | 2.02 | -6.508 | - | - | - | - | - | - | - | - | - | - | - | - |
Net margin | 6.08% | -20.96% | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | 0.0100 | -0.0200 | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 21-11-15 | 22-03-16 | 22-05-10 | 22-08-08 | 22-11-07 | 23-03-01 | 23-05-08 | 23-08-02 | 23-11-08 | 24-03-06 | 24-05-08 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 26.1 | 55 | 74.7 | 69.1 |
Net Cash position 1 | - | - | 5.37 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 0.8067 x | 2.229 x | 3.113 x | 1.898 x |
Free Cash Flow 1 | - | - | 18 | -4.83 | -12.2 | -4.2 | 5.6 |
ROE (net income / shareholders' equity) | - | - | 43.5% | 45.9% | -1.28% | 2.8% | 10.9% |
ROA (Net income/ Total Assets) | - | - | 21.5% | 16.1% | -0.48% | 4.1% | 7.3% |
Assets | - | - | 33.53 | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share 2 | - | - | 0.1000 | 0.0200 | 0.0200 | 0.0200 | 0.0400 |
Capex 1 | - | - | 17.9 | 12.1 | 20.1 | 12.7 | 5 |
Capex / Sales | - | - | 14.72% | 9.06% | 13.55% | 7.91% | 2.81% |
Announcement Date | 20-04-01 | 21-03-23 | 22-03-16 | 23-03-01 | 24-03-06 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.48% | 99.66M | |
+17.55% | 3.03B | |
+15.99% | 1.72B | |
+3.18% | 484M | |
+45.54% | 180M | |
+0.97% | 97.37M | |
+56.25% | 71.9M | |
+44.94% | 54.13M |
- Stock Market
- Equities
- MRMD Stock
- Financials MariMed Inc.